Parker Waichman LLP

Increased Scrutiny for Overseas Drug Company Clinical Trials

Overseas Drug Company Clinical Trials. Overseas health regulators are beginning to take a closer look at drug clinical trials conducted in their countries, following several well-publicized safety scandals, The Wall Street Journal reports.  The crackdowns have cheered many patient advocates, who say the growing reliance on overseas studies by Western drug companies raises ethical concerns. […]

Overseas Drug Company

Overseas Drug Company Clinical Trials. Overseas health regulators are beginning to take a closer look at drug clinical trials conducted in their countries, following several well-publicized safety scandals, The Wall Street Journal reports.  The crackdowns have cheered many patient advocates, who say the growing reliance on overseas studies by Western drug companies raises ethical concerns.

According to The Wall Street Journal, the death of an Indian infant during a trial for Prevnar-13, a pneumococcal vaccine being developed by Wyeth, prompted officials in that country to shut down the study.

The child died  within a week of receiving the third dose of the standard (not the experimental version) Prevnar vaccine.  Indian drug regulators investigating the death found evidence that the baby had a pre-existing cardiac disorder that should have disqualified him from the trial.

While India halted the Prevnar-13 trial, other countries where Wyeth is conducting similar studies allowed those to continue.

The Wall Street Journal also reports that Polish regulators are scrutinizing a Novartis clinical trial

The Wall Street Journal also reports that Polish regulators are scrutinizing a Novartis clinical trial for a bird flu vaccine after two elderly patients died. Age limits should have excluded both from the study.

The investigation found that subjects for the trial were recruited at a nursing home and homeless shelter.  That prompted investigators to notify the European Medicines Agency and the Polish Police.

While no link between the deaths and vaccine has been found, the recruiting irregularities are being investigated.

According to the Journal, criminal probes of some of those who enrolled patients is continuing.  Meanwhile, the problems have led to a delay of at least a year in approval of the vaccine by European authorities, the Journal said.

The Wall Street Journal article said 40% of trials sponsored by the global pharmaceutical industry in 2005 were conducted in low- and middle-income countries.  That practice  has been controversial in some quarters.

Overseas trials are cheaper for drug makers, mainly because the personnel who conduct them can be paid less

Overseas trials are cheaper for drug makers, mainly because the personnel who conduct them can be paid less.  But as the Wall Street Journal notes, critics charge some of these lower paid doctors and clinicians might feel pressured to boost enrollment or reconcile questionable data in order to keep drug company sponsors happy.

There’s also a growing concern in less developed countries about their citizens being used to test new drugs that they will not be able to afford once they come to market, the Journal said.

Despite the increased scrutiny faced by drug companies conducting clinical trials overseas, the pharmaceutical industry shows no signs of abandoning  overseas studies.  According to The Wall Street Journal, India has approved some 450 clinical trials this year, up from about 100 in 2005.

Wyeth also told the Journal that about 45% of its mid- and late-stage trial participants  now come from outside the U.S. and Western Europe.

Need Legal Help Regarding Overseas Drug Company?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Positive: Professionalism Always kept me informed in a timely manner
Donald Dodson
2 years ago
5 Star Reviews 150
Nicoleta Mereuta ,answers all my questions and she was polite. She was a pleasure to talk too.
Brenda Simmons
7 months ago
5 Star Reviews 150
Excellent professionals who fulfill their commitment..
William Contreras
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038